3rd Quarter - Report

DALRYMPLE & ASSOCIATES, LLC for EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION)

Firm
Client
Income
$46,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Biodefence vaccines and medical countermeasures

LobbyistCovered position, as disclosed
DONALD DALRYMPLE Principal

Contacted: Homeland Security, Dept of (DHS); Food & Drug Administration (FDA); SENATE; Centers For Disease Control & Prevention (CDC); Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.